ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 2604

$1.68M Total Retail Price of All Prescriptions

Rank: 4 out of 2604

928 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 928 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 928 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 19,578 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,214 757 S3 1 1
FUROSEMIDE 987 837 2 8
LEVOTHYROXINE SODIUM 927 710 3 4
SIMVASTATIN 858 675 4 2
OMEPRAZOLE 810 564 5 5
METOPROLOL TARTRATE 571 475 6 9
POTASSIUM CHLORIDE 505 409 7 16
LISINOPRIL 499 384 8 3
DONEPEZIL HCL 489 427 9 28
GABAPENTIN 465 310 10 12
WARFARIN SODIUM 455 386 11 13
AMLODIPINE BESYLATE 429 363 12 6
CITALOPRAM HBR 374 294 13 18
METFORMIN HCL 293 161 14 7
CIPROFLOXACIN HCL 271 187 15 59
RISPERIDONE 269 221 16 65
AZITHROMYCIN 268 184 17 33
TAMSULOSIN HCL 246 211 18 30
ROPINIROLE HCL 230 216 19 102
IBUPROFEN 230 108 19 32
CARVEDILOL 228 190 21 26
NAMENDA 224 176 22 37
PREDNISONE 219 148 23 34
MELOXICAM 214 139 24 36
FLUTICASONE PROPIONATE 212 101 25 31
CYMBALTA 204 111 26 44
METOPROLOL SUCCINATE 200 142 27 17
LANTUS 193 142 28 40
CLOPIDOGREL 193 141 28 39
CARBIDOPA-LEVODOPA 191 177 30 97
FENTANYL 180 123 S2 31 48
ZOLPIDEM TARTRATE 180 117 31 21
ESCITALOPRAM OXALATE 179 132 33 73
SERTRALINE HCL 178 139 34 23
POLYETHYLENE GLYCOL 3350 176 130 35 42
ATENOLOL 174 145 36 11
TRAMADOL HCL 169 120 37 15
HYDROCHLOROTHIAZIDE 168 136 38 10
ADVAIR DISKUS 167 98 39 41
DIGOXIN 163 159 40 71
NEXIUM 159 125 41 53
GLIMEPIRIDE 156 136 42 57
PANTOPRAZOLE SODIUM 146 119 43 64
PRAVASTATIN SODIUM 145 127 44 14
SINGULAIR 145 68 44 120
PLAVIX 143 111 46 75
CEPHALEXIN 141 77 47 74
RANITIDINE HCL 141 108 47 25
ISOSORBIDE MONONITRATE ER 134 130 49 38
SPIRIVA 132 95 50 45
MIRTAZAPINE 131 116 51 52
NYSTATIN 130 106 52 100
ATORVASTATIN CALCIUM 127 69 53 19
ALLOPURINOL 126 119 54 35
FAMOTIDINE 124 82 55 68
GLIPIZIDE 123 99 56 51
DIVALPROEX SODIUM 123 117 56 81
CELEBREX 120 61 58 114
INSULIN SYRINGE 119 67 59 109
NOVOLOG 117 110 60 89
SULFAMETHOXAZOLE-TRIMETHOPRIM 115 91 61 91
KLOR-CON M20 111 91 62 86
CLOTRIMAZOLE-BETAMETHASONE 104 63 63 138
SPIRONOLACTONE 103 94 64 78
LANTUS SOLOSTAR 102 82 65 84
CYCLOBENZAPRINE HCL 102 61 R 65 43
LEVETIRACETAM 101 49 67 96
TRICOR 94 47 68 132
TRIAMCINOLONE ACETONIDE 93 68 69 125
OXYBUTYNIN CHLORIDE 93 71 69 92
NYSTATIN-TRIAMCINOLONE 91 80 71 271
OLANZAPINE 91 47 71 115
FENOFIBRATE 87 33 73 69
BACLOFEN 86 35 74 101
PEN NEEDLE 86 55 74 145
MONTELUKAST SODIUM 86 41 74 213
BUMETANIDE 85 76 77 70
QUETIAPINE FUMARATE 84 62 78 66
PAROXETINE HCL 83 64 79 62
FLUOXETINE HCL 82 60 80 49
LIDODERM 81 76 81 80
CARISOPRODOL 80 14 R 82 54
TORSEMIDE 80 58 82 177
ALBUTEROL SULFATE 78 64 84 93
ALENDRONATE SODIUM 75 48 85 29
LEVEMIR 74 71 86 171
LOSARTAN POTASSIUM 74 72 86 20
IPRATROPIUM-ALBUTEROL 74 67 86 136
LANSOPRAZOLE 71 36 89 137
VENLAFAXINE HCL ER 69 54 90 107
ALPRAZOLAM 69 55 90 119
CLONIDINE HCL 68 47 92 56
SUCRALFATE 68 49 92 209
HYDROXYZINE HCL 67 39 R 94 214
DIVALPROEX SODIUM ER 66 29 95 212
LACTULOSE 66 61 95 108
EXELON 65 65 97 150
HYDROMORPHONE HCL 65 30 S2 97 175
PROAIR HFA 64 0 99 27
CHOLESTYRAMINE 63 33 100 315
OXYCODONE-ACETAMINOPHEN 62 29 S2 101 147
SYMBICORT 61 35 102 105
HYDRALAZINE HCL 61 49 102 85
SOTALOL 61 53 102 453
METFORMIN HCL ER 60 40 105 72
NAPROXEN 60 38 105 76
CILOSTAZOL 60 34 105 193
BETHANECHOL CHLORIDE 58 54 108 392
METOCLOPRAMIDE HCL 57 45 109 181
AMITRIPTYLINE HCL 57 20 R 109 82
ENALAPRIL MALEATE 56 50 111 50
ACETAMINOPHEN-CODEINE 56 50 S3 111 60
DIOVAN 56 56 111 123
MECLIZINE HCL 56 28 111 155
FLUCONAZOLE 55 36 115 160
MOMETASONE FUROATE 55 31 115 358
VALPROIC ACID 54 20 117 229
LORAZEPAM 52 52 118 190
SANTYL 51 32 119 254
MORPHINE SULFATE 51 50 S2 119 140
VENTOLIN HFA 50 13 121 63
TOPIRAMATE 50 0 121 143
HUMALOG 50 22 121 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.